Autolomous CEO Discusses AI and Machine Learning Applications in Pharmaceutical Development and Manufacturing with Pharmaceutical Technology®

Autolomous CEO and co-founder Alexander Seyf discussed the integration of artificial intelligence and machine learning within the pharmaceutical sector, specifically focusing on development and manufacturing processes, in a recent interview. The conversation highlighted how these technologies are being applied in the industry. Seyf’s insights, shared with Pharmaceutical Technology®, covered the practical uses of AI and machine learning in optimizing drug development and streamlining manufacturing operations. The discussion centered on the current adoption rates and potential future impact of these technologies within the pharmaceutical landscape.

Newsflash | Powered by GeneOnline AI
Date: April 14, 2025

Related posts:

FDA Granted Accelerated Approval to Vitrakvi (Larotrectinib) in November 2018 State Attorneys General Investigate PBM Influence Over Health Plans Amid Concerns of Self-Benefit Securing Biologic Drug Patents: Article Explores Strategies for a Market Representing Over 40% of Global Pharmaceutical Sales. Top 5 Generic Drug Makers Control 70% of Market: Blog Post Outlines Strategies for New Entrants

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後